Becoming Certified in Addiction Medicine through ABPM (1 CME)
Starting in the fall of 2017, ABPM will offer physicians who are certified by a Member Board of the American Board of Medical Specialties (ABMS) the opportunity to become certified in the subspecialty of addiction medicine. The next five years following the date of the first exam is an optimum time for physicians to become Board Certified in addiction medicine. Physicians who are already certified by any of the 24 member Boards and have substantial experience in the field of addiction medicine are eligible to apply to take the examination. During the first five years the examination is given, individuals will NOT be required to complete an addiction medicine fellowship. After that, a one-year addiction medicine fellowship will be required. Upcoming Dates/Deadlines: 2017 Exam Applications Open: April 3 thru May 31, 2017. 2017 Exam Dates: October 16-28, 2017. For more info see ABPM booth in exhibit hall or www.theabpm.org.
Marie A. Krousel-Wood
M.A. “Tonette” Krousel-Wood MD, MSPH, FACPM, FAHA is the Chair of the American Board of Preventive Medicine, Professor of Medicine in the Tulane School of Medicine, Professor of Epidemiology in the Tulane School of Public Health and Tropical Medicine, and serves in leadership roles including the Associate Provost for the Health Sciences at Tulane University.
She is actively engaged in NIH-funded clinical research and clinical trials focused on adherence to prescribed therapies, management of hypertension, health services and outcomes in patients with chronic cardiometabolic diseases. In addition to her own research, she is committed to training the next generation of scientists and co-directs pre- and post-doctoral career development programs including serving as the Principal Investigator and Research Director for the NIH K12 Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) faculty career development award. She has presented her research findings at regional, national, and international meetings and has collectively published over 100 peer-reviewed articles, reports and book chapters.
She has held numerous leadership positions nationally including member and Chair of the National Institutes of Health Study Section, Health Services Organization and Delivery, President of the Southern Society for Clinical Investigation, President of Delta Omega national public health honorary society, member of the Board of Regents for the American College of Preventive Medicine, Chair and Director of the American Board of Preventive Medicine, and member of the National Institutes of Health Center for Scientific Review (NIH-CSR) Advisory Council.
Benson Munger, PhD, is the Interim Executive Director of the American Board of Preventive Medicine.
Michael F. Weaver
Dr. Michael Weaver is Professor of Psychiatry and Medical Director of the Center for Neurobehavioral Research on Addiction at The University of Texas McGovern Medical School at Houston. He completed a Residency in Internal Medicine and a Clinical Research Fellowship in Addiction Medicine at Virginia Commonwealth University. He is involved in patient care, medical education, and research. Dr. Weaver has multiple publications in the field of addiction medicine. He treats patients at the Innovations Addiction Treatment Clinic at the Texas Medical Center in Houston, which provides medication-assisted treatment. He is the Sub-Board Chair for Addiction Medicine for the American Board of Preventive Medicine. He is a member of the ASAM Publications Council and on the Editorial Board for the Journal of Addiction Medicine.